Recall issued on Reumofan Plus supplement due to presence of dangerous ingredients


Recall issued on Reumofan Plus supplement due to presence of dangerous ingredientsThe makers of the health supplement Reumofan Plus Tablets has recalled 500 Lots of the product available at the consumer level because of the presence of two harmful ingredients.

In a statement from Samantha Lynn Inc., the affected Reumofan Plus Tablets include methocarbamol and diclofenac. The presence of these ingredients could result in life-threatening consequences for some people. Testing done by the Food and Drug Administration discovered the presence of these materials.  

Although the company has yet to receive any adverse event reports from consumers who reacted badly after taking Reumofan, taking these supplements could result in “hypersensitivity reactions and anaphylaxis and could cause a temporary and reversible increase in CNS depression” due to the presence of methocarbamol and diclofenac.

Samantha Lynn indicates in its recall statement that Reumofan Plus Tablets are taken in the treatment of muscle pain, arthritis, osteoporosis, bone cancer, and other conditions. The company has provided the following information to help consumers identify affected products: “Lots may include the following Lot number(s): 99515 ex096 and expires: 2016. The product is marketed in a green bottle containing 30 lavender round tablets and is distributed nationwide via the internet.”

Consumers who purchased their bottles of Reumofan Plus between February and June of this year through the company’s Web site are soon to receive an email regarding their options for returning any portions of the unused bottles.